C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1992
11/25/1992	EP0514413A1 Immunologically active peptides or polypeptides from the parvovirus b19.
11/25/1992	EP0514411A1 Polypeptides and dna encoding same, associated with human malaria parasites
11/25/1992	EP0427745A4 Solid phase assembly and reconstruction of biopolymers
11/25/1992	EP0416032A4 Agrichemical screens
11/25/1992	EP0348399B1 Sorbin and peptide derivatives which increase aborption by the mucous membranes
11/25/1992	EP0139676B1 Production and characterization of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins
11/25/1992	CN1066470A Process for producing monocyte chemotactic factor polypeptide and train for production thereof
11/25/1992	CA2331239A1 Structure, production and use of heregulin
11/24/1992	US5166329 Genetic engineering; mutants
11/24/1992	US5166322 Cysteine added variants of interleukin-3 and chemical modifications thereof
11/24/1992	US5166321 Cecropin polypetides with activity against Gram-positive and Gram-negative bacteria
11/24/1992	US5166320 Carrier system and method for the introduction of genes into mammalian cells
11/24/1992	US5166318 Anticoagulants
11/24/1992	US5166316 Polypeptides for genetic engineering
11/24/1992	US5166315 Sequence-specific binding polymers for duplex nucleic acids
11/24/1992	US5166195 Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
11/24/1992	US5166140 Use of certain nucleoside analogs to attenuate cancer cell resistance to DNA damaging chemotherapy
11/24/1992	US5166070 Vectors for the cloning and expression of heterologous genes in yeast and the yeast strains transformed by said vectors
11/24/1992	US5166068 Method of culturing protoplasts
11/24/1992	US5166060 Process for the preparation of pyridine-2,3-dicarboxylic acids
11/24/1992	US5166059 Genetic engineering to correct gene defects
11/24/1992	US5166057 Templates for gene expression
11/24/1992	US5166056 Recombinant trichosanthin and coding sequence
11/24/1992	US5165912 Reagents for diagnosis with antibodies reactive with enzymes
11/24/1992	CA2069262A1 Gene for aprt from plant tissue
11/24/1992	CA1310602C Yeast promoter and process for preparing heterologous protein
11/24/1992	CA1310601C Expression vectors
11/23/1992	CA2069147A1 Dna and its use
11/21/1992	CA2102292A1 The astrovirus human gastroenteritis agents and molecular cloning of corresponding cdnas
11/19/1992	EP0514207A2 Novel human neurokinin-1 receptor short form
11/19/1992	EP0514173A2 Methods and compositions for enzyme complementation assays using the omega region of beta-galactosidase
11/19/1992	EP0513921A2 Recombinant vaccine against Marek's disease
11/19/1992	EP0513884A1 Male-sterile plants, methods for obtaining male-sterile plants and recombinant DNA for use therein
11/19/1992	EP0513849A2 Zea mays plants and transgenic Zea mays plants regenerated from protoplasts or protoplast-derived cells
11/19/1992	EP0513806A1 Esterase genes, esterase, recombinant plasmids and transformants containing the recombinant plasmid and methods of producing optically active carboxylic acids and their enantiomeric esters using said transformants
11/19/1992	EP0513778A2 Hybrid monoclonal antibodies and compositions containing them
11/19/1992	EP0513565A1 Monoclonal antibodies against the plasmin-antiplasmin complex, process for their preparation and their use
11/19/1992	EP0513371A1 Human parainfluenza virus type 4a fusion protein and gene which codes for the same
11/19/1992	EP0513336A1 New variants derived from interferons of type i, production process thereof and their applications
11/19/1992	EP0513316A1 Analytical tracers for cancer, particularly malignant breast cancer.
11/19/1992	EP0513203A1 Diagnosis of hereditary retinal degenerative diseases
11/19/1992	EP0513201A1 Leukocyte-derived growth factor
11/19/1992	EP0513116A1 Self-inactivating bird vector
11/19/1992	EP0513090A1 Hepatitis a vaccines
11/19/1992	EP0513073A1 PROCESS FOR ENZYMATICAL CLEAVAGE OF RECOMBINANT PROTEINS BY MEANS OF IgA PROTEASES.
11/19/1992	EP0513054A1 Virus/herbicide resistance genes process for producing same and their use
11/19/1992	EP0491780A4 A membrane associated protein from plants which has nitrate reductase activity
11/18/1992	CN1066272A Process for preparation of anti-thrombin polypeptides
11/18/1992	CN1066193A Recursor form of boving growth hormone releasing factor and related dna compounds
11/18/1992	CN1019133B Monoclonal antibodies to pseudomonas aeruginosa flagella
11/18/1992	CN1019132B Anti-urokinase monoclonal antibody, matrix bearing it, test method and biochemical test kits which use it
11/18/1992	CA2068813A1 Hybrid monoclonal antibodies and compositions containing them
11/18/1992	CA2068372A1 Human neurokinin-1 receptor short form
11/17/1992	WO1992020372A1 Method of suppressing tumor formation in vivo by administering je/mlp-1
11/17/1992	US5164485 Modified hepatitis B virus surface antigen P31 and production thereof
11/17/1992	US5164482 Recombinant aprotinin variants genetically engineered process for the microbial preparation of homogeneously processed aprotinin variants and the therapeutic use thereof
11/17/1992	US5164481 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus
11/17/1992	US5164369 Asparagine, leucine, arginine, cysteine
11/17/1992	US5164366 Diabetes
11/17/1992	US5164316 Genetic engineering
11/17/1992	US5164313 Recombinant vaccinia virus encoding cytochromes P-450
11/17/1992	US5164310 Rapid regeneration of plant tissue
11/17/1992	US5164305 Producing protein, increased transcription
11/17/1992	US5164304 Method and vectors for stabilizing hirudin and human laminin b1 expression
11/17/1992	US5164303 Method for producing riboflavin with Candida famata
11/17/1992	US5164180 Bacillus thuringiensis isolates active against lepidopteran pests
11/17/1992	CA2109315A1 Method of suppressing tumor formation in vivo by administering je/mlp-1
11/17/1992	CA2068811A1 Protein from lactic acid bacteria
11/17/1992	CA2068764A1 Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
11/17/1992	CA1310286C Isolation of a gene encoding human thyrotropin beta subunit
11/16/1992	WO1992020808A1 Genomic modifications with homologous dna targeting
11/16/1992	EP0528827A4 Protein partner screening assays and uses thereof.
11/16/1992	CA2092695A1 Genomic modifications with homologous dna targeting
11/16/1992	CA2042625A1 Transgenic non-human animal carrying a non-infectious hiv genome
11/15/1992	WO1992020373A1 Heteroconjugate antibodies for treatment of hiv infection
11/15/1992	CA2102511A1 Heteroconjugate antibodies for treatment of hiv infection
11/14/1992	WO1992020805A1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
11/12/1992	WO1992020060A1 Electrophoretic display panel with tapered grid insulators and associated methods
11/12/1992	WO1992019973A1 Novel antibodies, and methods for their use
11/12/1992	WO1992019759A1 Reconstituted human antibody against human interleukin 6 receptor
11/12/1992	WO1992019758A1 Transmission-blocking vaccine against malaria
11/12/1992	WO1992019753A1 Genetic control of acetylation and pyruvylation of xanthan based polysaccharide polymers
11/12/1992	WO1992019750A1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor
11/12/1992	WO1992019749A1 Targeted delivery of genes encoding cell surface receptors
11/12/1992	WO1992019748A1 Herpesvirus particles and vaccine
11/12/1992	WO1992019747A1 Production of polyhydroxyalkanoate in plants
11/12/1992	WO1992019744A1 ACID α-AMYLASE
11/12/1992	WO1992019743A2 Hcv genomic sequences for diagnostics and therapeutics
11/12/1992	WO1992019742A1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT
11/12/1992	WO1992019741A1 Hbv virus surface proteins with reduced host carbohydrate
11/12/1992	WO1992019740A1 Multiple hepatitis b virus surface proteins which form particles
11/12/1992	WO1992019739A1 Novel nematode-active toxins and genes which code therefor
11/12/1992	WO1992019738A1 Microbial degradation of trichloroethylene, dichloroethylenes and aromatic pollutants
11/12/1992	WO1992019737A1 Process for producing a monocyte chemotactic factor polypeptide and a strain for the production thereof
11/12/1992	WO1992019736A1 Growth hormone antagonists
11/12/1992	WO1992019735A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND
11/12/1992	WO1992019734A1 Binding domains in notch and delta proteins
11/12/1992	WO1992019733A1 Thyroidal receptor for n-acetylglucosamine
11/12/1992	WO1992019731A1 Transgenic plants with altered polyol content
11/12/1992	WO1992019730A1 Dna construct for in vivo expression of a human gene

1 ... 3867 3868 3869 3870 3871 3872 3873 3874 3875 3876 3877 3878 3879 3880 3881 3882 3883 3884 3885 3886 3887 ... 4023